DMAC Starts Phase 2 Trial
DMAC DiaMedica Therapeutics announces first patients dosed in Phase 2 trial of DM199 for the treatment of fetal growth restriction
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
DMAC DiaMedica Therapeutics announces first patients dosed in Phase 2 trial of DM199 for the treatment of fetal growth restriction